Paranormal activity: Para-Esophageal/Gastric Hemorrhage in a Patient with a HeartMate II LVAD by Stone, Anna & Ravichandran, Ashwin
 The VAD Journal: https://doi.org/10.13023/VAD.2017.07 Page 1 of 5 
 
The VAD Journal: The journal of mechanical assisted circulation and heart failure 
 
 
 
 
 
 
Peer-Reviewed Case Report 
Paranormal activity: Para-Esophageal/Gastric 
Hemorrhage in a Patient with a HeartMate II LVAD 
   
Anna Stone* and Ashwin Ravichandran  
St Vincent's Indianapolis/Heart Center of Indiana, Indianapolis, IN 
Corresponding author: annasleder@gmail.com 
 
Abstract 
In this report we present an unusual case of non-traumatic, spontaneous para-
esophageal/para-gastric hemorrhage requiring multiple units of red blood cells in a 
female patient with a continuous flow left ventricular assist device. She presented 
with dysphagia and atypical chest pain 18 months post implantation, on the 
recommended anticoagulation regimen for HeartMate II support of ASA 81mg and 
international normalized ratio goal (INR) of 2-3 and was successfully managed 
with conservation support, volume resuscitation and multiple transfusions. Non-
traumatic causes of acute bleeding, including acquired platelet dysfunction are 
considered.   
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Introduction 
 
Mechanical circulatory support in the form of left ventricular assist devices 
(LVADs) have become the standard-of-care for selected patients with end-stage 
heart failure refractory to medical therapy.  Despite the improved survival in 
patients with the evolution in design from pulsatile flow to continuous flow (CF) 
devices, bleeding complications remain a significant problem, not the least of 
which is gastrointestinal (GI) bleeding. 1 In addition to the risks of bleeding related 
to anticoagulation, GI bleeding in CF LVADs has been attributed to the 
development of acquired von Willebrand disease (aVWD), diminished pulse 
pressure and pulsatility, advanced age, history of peptic ulcer disease, and  
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increased pump speed. 2- 4 Evidence of spontaneous bleeding from other anatomic 
sites are less well-described.  We present a case of a spontaneous para-
esophageal/gastric hemorrhage in a patient with a CF LVAD who was greater than 
one year post device implantation.  
Case report 
The patient was a 38 year old African American female with a history of non-
ischemic cardiomyopathy status post HeartMate II in February of 2015, obesity 
(BMI of 48), and dysfunctional uterine bleeding after LVAD controlled with an 
intrauterine device. The patient reported her usual state of health and had no 
significant prior LVAD complications until the day of presentation when she awoke 
with sudden onset, sharp, severe chest and back pain, dysphagia, nausea, and 
vomiting with clear emesis.  Computed tomography with angiogram (CTA) of the 
chest revealed no signs of dissection, but did reveal a 7.5 x5.9 cm hypodense 
lesion posterior to the left lobe of the liver and anterior to the stomach, with mild 
dilation of the distal esophagus and air/fluid levels seen in the proximal 
esophagus.  Initial labs were notable for an INR of 2.86 and hemoglobin of 8.4g/dl 
(baseline ~9.5g/dl), which rapidly decreased to 6.7g/dl over the next few hours. 
The severe chest pain and vomiting continued, and with the assistance of the 
gastrointestinal (GI) team, a nasogastric tube was endoscopically placed, and 
visual examination revealed severe, diffuse  mucosal changes concerning for 
ischemia from external compression. A subsequent barium swallow revealed a 
large mass concerning for hematoma, likely external to the esophagus, causing 
severe luminal narrowing and a high degree of obstruction (Figure 1).  Repeat 
CTA revealed a much larger (9.1x 4.5x 10cm), evolving hematoma (Figure 2) 
which also resulted in gastric compression (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Esophagram revealing para-
esophageal hematoma with 
esophageal obstruction 
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Figure 2. Cross and coronal sections of CTA of chest revealing para-
esophageal and para-gastric hematoma with LVAD.  
 
Figure 3. Sagittal section of CT with oral contrast revealing 
paraesophageal/paragastric hematoma causing gastric compression. 
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After volume and transfusion resuscitation, reversal of anticoagulation with fresh 
frozen plasma, and surgical evaluation, conservative management was 
undertaken given her clinical stability with no other  source of bleeding despite 
interventional angiographic evaluation. She then tolerated increasing doses of 
intravenous heparin, was bridged to warfarin and kept nothing per os (NPO) other 
than medications for several days due to concerns over ischemic esophagitis.  She 
slowly progressed to mechanical soft diet at time of discharge with mild residual 
dysphagia, 16 days after presentation. 
Discussion  
The association between CF LVADs and bleeding diatheses are well-known, in 
part due to the aforementioned phenomenon of aVWD, resulting from the sheer 
stress on the von Willebrand factor from the CF-LVAD leading to platelet 
dysfunction.5 Another mechanism independent and specifically related to the 
increased risk of GI bleeding in CF LVADs is similar to that of Heyde’s syndrome 
seen in aortic stenosis.  Heyde’s syndrome is the theory of an abnormal pulse 
wave resulting in the distention of sub-mucosal venous plexuses of the GI tract, 
subsequent angiodysplasia and arteriovenous malformations (AVMs)with poorly 
perfused, and friable gastrointestinal mucosa.6   To our knowledge, this is the first 
report of a spontaneous paraesophageal/mucosal bleed that is not related to the 
common GI or perioperative bleeding reported in this population. Understanding 
the other potential mechanisms and risk factors for increased bleeding in LVAD 
patients is crucial to the prevention and treatment of morbidity and mortality in this 
already high risk population.  
 
How sex or BMI influences the risks of these types of bleeds have yet to be 
elucidated. Recently, an increased incidence of thrombotic and hemorrhagic 
events have been identified in the female HeartMate II population as compared to  
males,7 with a more recent single center report  identifying an increase in bleeding 
complications in females regardless of  CF-LVAD type.8 Additionally, there is a 
higher risk of bleeding in patients with lower body mass index (BMI), which is 
clearly not the case for this patient with a BMI of 48.9 Taking all of this into 
consideration along with an INR within therapeutic range, determining the etiology 
of our patient’s spontaneous paraesophageal/mucosal bleed remains a challenge.  
    
Currently the mainstay of prevention for bleeding in LVAD patients is mechanical 
and pharmacologic intervention including monitoring INRs closely and reducing 
pump speed, which may be associated with decreased bleeding.4 Blood pressure 
control is important in reducing risk of intracerebral bleeding. Determining the 
risks, prevention and treatment of bleeding not only impacts short-term morbidity, 
but also has several long-term implications.  For example, patients with LVADs 
who have experienced GI bleeding have a decrease in future heart transplant 
probability.  While the mechanism of this relationship is unclear, speculation 
regarding allosensitization from receiving blood products prior to heart transplant is 
purported. 10  Further research and reports on bleeding in this patient population is 
crucial to discovering targeted methods for the prevention and treatment of 
bleeding and its associated implications on morbidity and mortality in the LVAD 
population.  
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